Cequent to Receive European, Korean Patents on RNAi Technology
Cequent Pharmaceuticals said this week that it has received notices that the European Patent Office and the Korean Intellectual Property Office intend to grant patents covering the company’s core RNAi technology.
Leave a Response
You must be logged in to post a comment.
